Cystatin C is a disease‐associated protein subject to multiple regulation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
A protease inhibitor, cystatin C (Cst C), is a secreted cysteine protease inhibitor abundantly expressed in body fluids. Clinically, it is mostly used to measure glomerular filtration rate as a marker for kidney function due to its relatively small molecular weight and easy detection. However, recent findings suggest that Cst C is regulated at both transcriptional and post‐translational levels, and Cst C production from haematopoietic cell lineages contributes significantly to the systematic pools of Cst C. Furthermore, Cst C is directly linked to many pathologic processes through various mechanisms. Thus fluctuation of Cst C levels might have serious clinical implications rather than a mere reflection of kidney functions. Here, we summarize the pathophysiological roles of Cst C dependent and independent on its inhibition of proteases, outline its change of expression by various stimuli, and elucidate the regulatory mechanisms to control this disease‐related protease inhibitor. Finally, we discuss the clinical implications of these findings for translational gains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Cysteine cathepsins: From structure, function and regulation to new frontiers
Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., & Turk, D. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.002 · Cited by 1,377
Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion
Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.-L., Metivier, D., Ojcius, D. M., Jäättelä, M., & Kroemer, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021952 · Cited by 483
Risch, L., Herklotz, R., Blumberg, A., & Huber, A. R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.11.2055 · Cited by 343 · cited 1×
“For example, body composition, thyroid function, glucocorticoid and C-reactive protein levels or even cigarette smoking and pregnancy status of the candidates examined have been found to affect Cst C blood concentration, 9, 10 let alone its alteration in patients with cancer, HIV infection, cardiovascular diseases and…”
BackgroundKitamura, H., Kamon, H., Sawa, S.-I., Park, S.-J., Katunuma, N., Ishihara, K., Murakami, M., & Hirano, T. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.010 · Cited by 223 · cited 2×
“27 However, a separate study using mouse primary DCs isolated from Cst C-deficient mice demonstrated that Cst C is neither necessary nor sufficient to control MHCII expression and antigen presentation in DCs.”
BackgroundManoury, B., Gregory, W. F., Maizels, R. M., & Watts, C. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00118-x · Cited by 223 · cited 1×
“26 Further experiments using bone marrow-derived DCs indicate that interleukin 6 (IL-6)mediated signal transducer and activator of transcription 3 (STAT3) activation decreased Cst C expression and MHCII αβ dimer levels.”
BackgroundPromoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells
Bjarnadóttir, M., Grubb, A., & Ólafsson, Í. (1995) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519509110261 · Cited by 157
Warfel, A. H., Zucker-Franklin, D., Frangione, B., & Ghiso, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.6.1912 · Cited by 126 · cited 1×
“84 Likewise, inflammatory cytokine IL-6 signaling in vivo was found to decrease Cst C expression in DCs.”
BackgroundCystatin C Antagonizes Transforming Growth Factor β Signaling in Normal and Cancer Cells
Sokol, J. P., & Schiemann, W. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.183.2.3 · Cited by 121 · cited 2×
“13, 51, 90 Clinically, a significant influence of circulating Cst C levels by TGF-β1 were also observed in patients with thyroid dysfunction, and both Cst C mRNA and protein levels were increased by TGF-β in cultured human hepatoblastoma cells.”
BackgroundHuh, C. G., Håkansson, K., Nathanson, C. M., Thorgeirsson, U. P., Jonsson, N., Grubb, A., Abrahamson, M., & Karlsson, S. (1999) · Molecular Pathology · doi:10.1136/mp.52.6.332 · Cited by 119
Macrophage responses to interferon-γ are dependent on cystatin C levels
Frendéus, K. H., Wallin, H., Janciauskiene, S., & Abrahamson, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.05.005 · Cited by 51
Involvement of cystatin C in pathophysiology of CNS diseases
Nagai, A. (2008) · Frontiers in Bioscience · doi:10.2741/2941 · Cited by 44 · cited 1×
“20 Recent studies indicated that the roles of Cst C in neuronal cell apoptosis induction include decreasing B-cell leukemia-2 (Bcl-2) and increasing active caspase-9 protein levels via the Jun N-terminal kinase (JNK)-dependent pathway, 21 and upregulation and accumulation of the insoluble α-synuclein in oligodendrocyt…”
BackgroundIncreased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study
Xu, N., Zhang, Y.-Y., Lin, Y., Bao, B., Zheng, L., Shi, G.-P., & Liu, J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0309 · Cited by 15 · cited 1×
“14, 15 Thus, the oscillation of blood Cst C levels could actually reflect the change of Cst C production, consumption, inactivation or fibrillation (mentioned later) rather than its filtration in the kidney, and the readout of plasma Cst C concentration might have different clinical implications.”
Background
Cited by
Involvement of cystatin C in immunity and apoptosis
Zi, M., & Xu, Y. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.006 · Cited by 170
“Furthermore, the preferential expression pattern of cystatin C in monocyte/macrophage and DCs is of clinical relevance in view of the recent reports showing that these cell types are present in tissues where cystatin C plays pathological roles in inflammatory diseases such as atherosclerosis and angiopathy [65].”
BackgroundSelf-citationOn the role of cystatin C in cancer progression
Leto, G., Crescimanno, M., & Flandina, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.013 · Cited by 84
Alternative TSSs are co‐regulated in single cells in the mouse brain
Karlsson, K., Lönnerberg, P., & Linnarsson, S. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167374 · Cited by 32
“…C has been implicated in a number of conditions including apoptosis, antigen presentation, atherosclerosis and pathogen invasion, and the level of Cst3 mRNA can be influenced by different stimuli like inflammatory cytokines, pathogens, growth factors, hormones and oxidative stress (Xu et al, 2015).”
BackgroundCancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor
Zhao, Y., Lu, T., Song, Y., Wen, Y., Deng, Z., Fan, J., Zhao, M., Zhao, R., Luo, Y., xie, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202204177 · Cited by 29
Sun, T., Chen, Q., & Li, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03509-3 · Cited by 19
Metadata
- Authors
- Xu, Y., Ding, Y., Li, X., & Wu, X.
- Venue
- Immunology & Cell Biology
- Publisher
- Wiley
- Published
- 2015-02-03
- Volume
- 93
- Issue
- 5
- Pages
- 442-451
- ISSN
- 0004-945X (ISSN-L)
- 0818-9641
- 1440-1711
- OpenAlex
- W2049931789
- Cited by
- 111
- References
- 13
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.